Interocular Asymmetry of Visual Field Defects in Primary Open Angle Glaucoma and Primary Angle-closure Glaucoma
Overview
Affiliations
Aim: To compare the interocular asymmetry in visual field loss of patients with primary open-angle (POAG) and primary angle-closure glaucoma (PACG).
Methods: Subjects entering a prospective, randomised, controlled trial of intraoperative 5-fluorouracil in glaucoma surgery in Singapore were included. Preoperative visual field testing was performed using automated white-on-white perimetry (24-2 test pattern, threshold program, Mk II, Model 750, Zeiss-Humphrey, San Leandro, CA, USA). A minimum of two tests were required with mean deviation within 2 dB on two tests, fixation losses <20%, false positives <33%, and false negatives <33%. The second field was scored using AGIS II criteria and the 'mean asymmetry score' defined as the mean difference between eyes for both AGIS scores and global indices.
Results: In 230 subjects assessed (128 POAG, 102 PACG), mean interocular asymmetry of visual field loss was greater for the PACG group. The mean AGIS asymmetry scores for total (PACG=9.21+/-6.87 vs POAG=6.48+/-5.58, P=0.001), superior (PACG=4.31+/-3.39 vs POAG=3.35+/-3.13, P=0.035), and inferior (PACG=4.43+/-3.31 vs POAG=2.64+/-2.77, P<0.0001) areas and mean deviation (MD) asymmetry scores (PACG=6.89+/-13.22 vs POAG=1.66+/-16.97, P=0.012) were all significantly different. Interocular correlation of visual field loss for POAG was significant; total AGIS, r=0.27 (P=0.003), superior field AGIS, r=0.24 (P=0.008), inferior field AGIS, r=0.34 (P=0.0001), and MD, r=0.27 (P=0.003). In PACG, there was no significant correlation between eyes; total AGIS, r=-0.02 (P=0.85), superior field AGIS, r=-0.02 (P=0.82), inferior field AGIS, r=-0.17 (P=0.87), and MD, r=0.015 (P=0.89).
Conclusion: There was a greater asymmetry of visual field loss between eyes, as measured by AGIS scores and MD, in PACG than that in POAG.
Binocular head-mounted chromatic pupillometry can detect structural and functional loss in glaucoma.
Quan Y, Duan H, Zhan Z, Shen Y, Lin R, Liu T Front Neurosci. 2023; 17:1187619.
PMID: 37456990 PMC: 10346847. DOI: 10.3389/fnins.2023.1187619.
Kang J, Wang M, Frueh L, Rosner B, Wiggs J, Elze T Transl Vis Sci Technol. 2022; 11(7):21.
PMID: 35877093 PMC: 9339699. DOI: 10.1167/tvst.11.7.21.
Parikh R, Kitnarong N, Jonas J, Parikh S, Thomas R Indian J Ophthalmol. 2021; 69(7):1833-1838.
PMID: 34146039 PMC: 8374789. DOI: 10.4103/ijo.IJO_2442_20.
Gracitelli C, Tatham A, Zangwill L, Weinreb R, Abe R, Diniz-Filho A Invest Ophthalmol Vis Sci. 2016; 57(4):1738-46.
PMID: 27064394 PMC: 4829086. DOI: 10.1167/iovs.15-18079.
Tatham A, Meira-Freitas D, Weinreb R, Marvasti A, Zangwill L, Medeiros F Invest Ophthalmol Vis Sci. 2013; 55(1):513-22.
PMID: 24282221 PMC: 3907131. DOI: 10.1167/iovs.13-12921.